HK1144553A1 - Use of an acetylsalicylic acid salt for the treatment of viral infections - Google Patents
Use of an acetylsalicylic acid salt for the treatment of viral infectionsInfo
- Publication number
- HK1144553A1 HK1144553A1 HK10111089.7A HK10111089A HK1144553A1 HK 1144553 A1 HK1144553 A1 HK 1144553A1 HK 10111089 A HK10111089 A HK 10111089A HK 1144553 A1 HK1144553 A1 HK 1144553A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- treatment
- acid salt
- viral infections
- acetylsalicylic acid
- acetylsalicylic
- Prior art date
Links
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical class CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 title 1
- 208000036142 Viral infection Diseases 0.000 title 1
- 230000009385 viral infection Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
- A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Pulmonology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Otolaryngology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Optics & Photonics (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pathology (AREA)
- Physics & Mathematics (AREA)
- Toxicology (AREA)
- Urology & Nephrology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Dispersion Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102008004386A DE102008004386A1 (de) | 2008-01-14 | 2008-01-14 | Verwendung eines Acetylsalicylsäuresalzes zur Behandlung viraler Infektionen |
| PCT/DE2009/000033 WO2009089822A2 (de) | 2008-01-14 | 2009-01-14 | Verwendung eines acetylsalicylsäuresalzes zur behandlung viraler infektionen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1144553A1 true HK1144553A1 (en) | 2011-02-25 |
Family
ID=40765574
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK10111089.7A HK1144553A1 (en) | 2008-01-14 | 2010-11-29 | Use of an acetylsalicylic acid salt for the treatment of viral infections |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US9492413B2 (es) |
| EP (1) | EP2249866B1 (es) |
| JP (1) | JP2011509928A (es) |
| KR (1) | KR20100103845A (es) |
| CN (2) | CN101909650A (es) |
| AU (1) | AU2009204574B2 (es) |
| BR (1) | BRPI0906851B1 (es) |
| CA (1) | CA2714286C (es) |
| DE (1) | DE102008004386A1 (es) |
| DK (1) | DK2249866T3 (es) |
| ES (1) | ES2392379T3 (es) |
| HK (1) | HK1144553A1 (es) |
| HR (1) | HRP20120812T1 (es) |
| IL (1) | IL206450A (es) |
| MX (1) | MX2010007670A (es) |
| PL (1) | PL2249866T3 (es) |
| PT (1) | PT2249866E (es) |
| RU (1) | RU2524304C2 (es) |
| SI (1) | SI2249866T1 (es) |
| WO (1) | WO2009089822A2 (es) |
| ZA (1) | ZA201004888B (es) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9757395B2 (en) | 2012-12-20 | 2017-09-12 | Otitopic Inc. | Dry powder inhaler and methods of use |
| US9757529B2 (en) | 2012-12-20 | 2017-09-12 | Otitopic Inc. | Dry powder inhaler and methods of use |
| EP2991634A1 (en) | 2013-04-30 | 2016-03-09 | Otitopic Inc. | Dry powder formulations and methods of use |
| DK3107548T3 (da) | 2014-02-20 | 2022-07-18 | Otitopic Inc | Tørpulverformuleringer til inhalation |
| JP6818676B2 (ja) * | 2014-05-16 | 2021-01-20 | アトリバ セラピューティクス ゲーエムベーハー | インフルエンザウイルスおよび黄色ブドウ球菌の重感染に対する新規の抗感染戦略 |
| DE102014111892A1 (de) | 2014-08-20 | 2016-02-25 | Eberhard Karls Universität Tübingen Medizinische Fakultät | Prophylaxe und Behandlung einer Infektion mit dem Hantavirus |
| DK3393517T3 (da) * | 2015-12-22 | 2021-11-01 | Aspiair Gmbh | Acetylsalicylsyre til anvendelse til behandling af moderat til alvorlig influenza |
| WO2017210658A1 (en) * | 2016-06-03 | 2017-12-07 | Otitopic Inc. | Dry powder formulations for inhalation |
| AU2017383071B2 (en) * | 2016-12-23 | 2021-04-29 | Aspiair Gmbh | Improved synthesis of lysine acetylsalicylate · glycine particles |
| US10786456B2 (en) | 2017-09-22 | 2020-09-29 | Otitopic Inc. | Inhaled aspirin and magnesium to treat inflammation |
| CN111315363B (zh) | 2017-09-22 | 2022-10-11 | 奥迪托皮克股份有限公司 | 含有硬脂酸镁的干粉组合物 |
| KR20220055697A (ko) | 2020-10-27 | 2022-05-04 | 강원대학교산학협력단 | 살리신을 유효성분으로 함유하는 허혈성 뇌혈관 질환 예방용 조성물 |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS4856815A (es) | 1971-11-13 | 1973-08-09 | ||
| DE69229070T2 (de) | 1991-02-09 | 1999-11-18 | B S D Bio Science Dev Snc Di O | Antireaktive antiasthmatische Wirkung von Acetylsalicylsäure durch Inhalation |
| AU666852B2 (en) * | 1991-05-01 | 1996-02-29 | Henry M. Jackson Foundation For The Advancement Of Military Medicine | A method for treating infectious respiratory diseases |
| BE1010692A6 (nl) * | 1996-10-15 | 1998-12-01 | Fogel Raphiel | Aerosoldoseerinrichting en spuitkap hierbij aangewend. |
| GB2306109B (en) * | 1997-02-07 | 1997-09-24 | John Wright | A zinc containing composition as a common cold prophylactic |
| RU2131750C1 (ru) * | 1997-11-21 | 1999-06-20 | Фролов Владимир Федорович | Дыхательный тренажер |
| US20020064542A1 (en) * | 1999-06-29 | 2002-05-30 | George Endel Deckner | Tissue products utilizing water soluble films as carriers for antiviral compositions and process for making |
| DE10029119B4 (de) | 2000-06-14 | 2005-12-22 | Institut für Aerosol Medizin InAMed GmbH | Inhalationsvorrichtung |
| DE10034802A1 (de) * | 2000-07-18 | 2002-01-31 | Bayer Ag | Stabile Salze von O-Acetylsalicylsäure mit basischen Aminosäuren |
| DE10123749A1 (de) | 2001-05-16 | 2002-12-12 | Inamed Gmbh | Vorrichtung zum Verabreichen von Aerosolen |
| US6475526B1 (en) * | 2001-06-05 | 2002-11-05 | Jeffrey B. Smith | Zinc containing compositions for anti-viral use |
| KR20040040474A (ko) * | 2001-09-27 | 2004-05-12 | 가부시키가이샤 디나벡크 겐큐쇼 | 바이러스 벡터 탑재 유전자 발현의 제어방법 |
| DE10202019A1 (de) | 2002-01-18 | 2003-07-24 | Bayer Ag | Stabile Salze von o-Acetylsalicylsäure mit basischen Aminosäuren II |
| CN1418635A (zh) * | 2002-12-19 | 2003-05-21 | 王登之 | 治疗感冒发热的阿司匹林口腔崩解片及其制备方法 |
| DE10300222A1 (de) | 2003-01-03 | 2004-07-15 | MedInnova Gesellschaft für medizinische Innovationen aus akademischer Forschung mbH | Verwendung von Wirksubstanzen zur Prophylaxe und/oder Therapie von Viruserkrankungen |
| DE10313636A1 (de) * | 2003-03-26 | 2004-10-14 | MedInnova Gesellschaft für medizinische Innovationen aus akademischer Forschung mbH | Verwendung von Wirksubstanzen zur Vorbeuge oder Behandlung von Viruserkrankungen sowie Testsystem zum Auffinden solcher Wirksubstanzen |
| US20060166901A1 (en) * | 2005-01-03 | 2006-07-27 | Yu Ruey J | Compositions comprising O-acetylsalicyl derivatives of aminocarbohydrates and amino acids |
| EP1700614B1 (de) | 2005-03-08 | 2013-05-08 | Activaero GmbH | Inhalationsvorrichtung |
| ITMI20050417A1 (it) * | 2005-03-15 | 2006-09-16 | Medestea Res & Production S R L | Uso di farmaci anti-infiammatori non steroidei per via inalatoria nella terapia della bronchite acuta e cronica |
| DE102005025283A1 (de) * | 2005-06-02 | 2006-12-07 | Bayer Healthcare Ag | Stabiler Wirkstoffkomplex von Salzen der o-Acetylsalicylsäure mit basischen Aminosäuren und Glycin |
| ES2290827T3 (es) | 2005-07-06 | 2008-02-16 | Activaero Gmbh | Valvula regulable y dispositivo para inhalar. |
| DE102005053358A1 (de) * | 2005-11-07 | 2007-05-10 | Lenk, Norbert, Dr. | Vorrichtung zur gesteuerten Bereitstellung von Ozon |
-
2008
- 2008-01-14 DE DE102008004386A patent/DE102008004386A1/de not_active Withdrawn
-
2009
- 2009-01-14 CN CN2009801021816A patent/CN101909650A/zh active Pending
- 2009-01-14 AU AU2009204574A patent/AU2009204574B2/en active Active
- 2009-01-14 EP EP09701974A patent/EP2249866B1/de active Active
- 2009-01-14 ES ES09701974T patent/ES2392379T3/es active Active
- 2009-01-14 PT PT09701974T patent/PT2249866E/pt unknown
- 2009-01-14 US US12/679,251 patent/US9492413B2/en active Active
- 2009-01-14 CN CN201510833722.XA patent/CN105477005A/zh active Pending
- 2009-01-14 PL PL09701974T patent/PL2249866T3/pl unknown
- 2009-01-14 RU RU2010133870/14A patent/RU2524304C2/ru active
- 2009-01-14 JP JP2010541691A patent/JP2011509928A/ja active Pending
- 2009-01-14 BR BRPI0906851-1A patent/BRPI0906851B1/pt active IP Right Grant
- 2009-01-14 MX MX2010007670A patent/MX2010007670A/es active IP Right Grant
- 2009-01-14 WO PCT/DE2009/000033 patent/WO2009089822A2/de active Application Filing
- 2009-01-14 SI SI200930355T patent/SI2249866T1/sl unknown
- 2009-01-14 CA CA2714286A patent/CA2714286C/en active Active
- 2009-01-14 DK DK09701974.9T patent/DK2249866T3/da active
- 2009-01-14 KR KR1020107016369A patent/KR20100103845A/ko not_active Application Discontinuation
-
2010
- 2010-06-17 IL IL206450A patent/IL206450A/en active IP Right Grant
- 2010-07-12 ZA ZA2010/04888A patent/ZA201004888B/en unknown
- 2010-11-29 HK HK10111089.7A patent/HK1144553A1/xx unknown
-
2012
- 2012-10-11 HR HRP20120812AT patent/HRP20120812T1/hr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2714286A1 (en) | 2009-07-23 |
| US9492413B2 (en) | 2016-11-15 |
| DE102008004386A1 (de) | 2009-07-23 |
| US20120017892A1 (en) | 2012-01-26 |
| JP2011509928A (ja) | 2011-03-31 |
| CA2714286C (en) | 2016-05-24 |
| WO2009089822A3 (de) | 2010-02-25 |
| EP2249866B1 (de) | 2012-08-15 |
| WO2009089822A2 (de) | 2009-07-23 |
| IL206450A (en) | 2015-08-31 |
| IL206450A0 (en) | 2010-12-30 |
| SI2249866T1 (sl) | 2012-11-30 |
| KR20100103845A (ko) | 2010-09-28 |
| PT2249866E (pt) | 2012-11-05 |
| CN105477005A (zh) | 2016-04-13 |
| ES2392379T3 (es) | 2012-12-10 |
| ZA201004888B (en) | 2011-04-28 |
| AU2009204574B2 (en) | 2014-05-29 |
| RU2010133870A (ru) | 2012-04-20 |
| AU2009204574A1 (en) | 2009-07-23 |
| CN101909650A (zh) | 2010-12-08 |
| HRP20120812T1 (hr) | 2012-11-30 |
| DK2249866T3 (da) | 2012-10-22 |
| MX2010007670A (es) | 2010-10-08 |
| BRPI0906851A2 (pt) | 2020-08-18 |
| RU2524304C2 (ru) | 2014-07-27 |
| PL2249866T3 (pl) | 2012-12-31 |
| BRPI0906851B1 (pt) | 2022-02-08 |
| EP2249866A2 (de) | 2010-11-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1144553A1 (en) | Use of an acetylsalicylic acid salt for the treatment of viral infections | |
| AP3103A (en) | Derivatives of purine or deazapurine useful for the treatment of (inter alia)viral infections | |
| PL2898885T3 (pl) | Pochodne pirolopirymidynowe do zastosowania w leczeniu zakażeń wirusowych | |
| PL2646425T3 (pl) | Kwasy indanyloksydihydrobenzofuranylooctowe użyteczne do leczenia zespołu metabolicznego | |
| EP2552203A4 (en) | COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF VIRUS INFECTIONS | |
| BR112013014943A2 (pt) | compostos úteis para o tratamento de aids | |
| LT2523661T (lt) | Nkcc inhibitoriai autizmo gydymui | |
| HK1156038A1 (en) | Compounds and pharmaceutical compositions for the treatment of viral infections | |
| HK1144794A1 (en) | Devices for treatment of viral infections | |
| PL2521562T3 (pl) | Ev576 do zastosowania w leczeniu zakażeń wirusowych dróg oddechowych | |
| IL199829A0 (en) | Use of substituted pyranone acid derivatives for the treatment of metabolic syndrome | |
| IL232384A (en) | Use of lupanate compounds or lupanic acid for the preparation of anti-gout drugs | |
| PL2022504T3 (pl) | Maść do leczenia hemoroidów | |
| PL2903608T3 (pl) | Kompozycja farmaceutyczna obejmująca kwas propionowy do stosowania w leczeniu infekcji wirusowych | |
| ITMI20080195A1 (it) | Procedimento per la preparazione di solifenacin | |
| EP2157089A4 (en) | THERAPEUTIC USES OF IMIDAZOL-5-CARBOXYLIC ACID DERIVATIVES | |
| ZA201306342B (en) | The treatment of viral infections | |
| HK1139050A1 (en) | Medicament for the treatment of pneumonia | |
| PT2647369T (pt) | Pacap para o tratamento de infeções virais em organismos aquáticos | |
| GB0817437D0 (en) | Compounds for the treatment of flaviviral infections | |
| GB0814216D0 (en) | Compounds for the treatment of flaviviral infections | |
| GB0819518D0 (en) | Compounds for the treatment of flaviviral infections | |
| GB0908672D0 (en) | Compounds for the treatment of flaviviral infections | |
| GB0809319D0 (en) | The treatment of puritus |